---
title: "Clearside Biomedical Files for Chapter 11 Bankruptcy in Delaware"
description: "Clearside Biomedical Inc. has filed for Chapter 11 bankruptcy in Delaware, submitting its Monthly Operating Report for the period ending November 30, 2025. The report, signed by CEO George Lasezkay, s"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/270986940.md"
published_at: "2025-12-29T11:15:08.000Z"
---

# Clearside Biomedical Files for Chapter 11 Bankruptcy in Delaware

> Clearside Biomedical Inc. has filed for Chapter 11 bankruptcy in Delaware, submitting its Monthly Operating Report for the period ending November 30, 2025. The report, signed by CEO George Lasezkay, states that the company has no full-time employees and reports no income or expenses. Currently, no reorganization plan or disclosure statement has been submitted to the court.

Clearside Biomedical Inc. has filed its Monthly Operating Report for the period ending November 30, 2025, as part of its ongoing Chapter 11 proceedings in the United States Bankruptcy Court for the District of Delaware. The report, signed by Chief Executive Officer George Lasezkay, confirms that the company currently has no full-time employees and reports no income or expenses for the period. The filing also indicates that, at this time, no plan of reorganization or disclosure statement has been submitted to the court. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Clearside Biomedical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-332152), on December 29, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [CLSDQ.US - CLEARSIDE BIOMEDICAL INC](https://longbridge.com/en/quote/CLSDQ.US.md)
- [CLSD.US - Clearside Biomedical](https://longbridge.com/en/quote/CLSD.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Clearside Biomedical Faces Nasdaq Delisting After Bankruptcy Filing | Clearside Biomedical Inc. faces Nasdaq delisting after filing for Chapter 11 bankruptcy. Trading was suspended on Decemb | [Link](https://longbridge.com/en/news/268997434.md) |
| 15:18 ETIn HelloNation, Tax Planning Expert Sharron Cirillo of Middletown, Delaware, Explains Year-Round Tax Planning for Delaware Businesses | A HelloNation article by tax planning expert Sharron Cirillo emphasizes the importance of year-round tax planning for De | [Link](https://longbridge.com/en/news/276076381.md) |
| 12:17 ETYoung Immigrants Advancing Biomedical Science Eligible for $50,000 Vilcek Prizes for Creative Promise | The Vilcek Foundation is accepting applications for the 2027 Vilcek Prizes for Creative Promise in Biomedical Science un | [Link](https://longbridge.com/en/news/276151122.md) |
| REG - Morgan StanleyEurope Oxford Biomedica PLC - Form 8.5 (EPT/NON-RI) - Oxford Biomedica plc | Morgan Stanley Europe SE disclosed its position regarding Oxford Biomedica PLC in accordance with Rule 8.5 of the Takeov | [Link](https://longbridge.com/en/news/276423354.md) |
| REG - Liontrust Asset Mgmt Oxford Biomedica PLC - Form 8.3 - Oxford Biomedica Plc | Liontrust Asset Management PLC disclosed an opening position in Oxford Biomedica PLC, reporting ownership of 2,257,968 s | [Link](https://longbridge.com/en/news/276241671.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.